Emerging evidence suggests that UBR5 is a key regulator of the ubiquitin-proteasome system (UPS) in cancer progression, such as CDK9 in melanoma [20], C/EBPα in pancreatic cancer [9], and MOAP-1 in ovarian cancer [21]. This evidence concerns the gene UBR5 and ovarian carcinoma.